<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03816293</url>
  </required_header>
  <id_info>
    <org_study_id>2018-1300</org_study_id>
    <nct_id>NCT03816293</nct_id>
  </id_info>
  <brief_title>SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections</brief_title>
  <acronym>SUpPressSSI</acronym>
  <official_title>SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland, College Park</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Acelity</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our goal is to provide data that will give surgeons and hospitals clear recommendations on&#xD;
      the use of NPWT for Cesarean section, abdominal hysterectomy and colon surgeries in patients&#xD;
      with diabetes and/or obesity. We also want to understand the patient experience with the&#xD;
      dressing so that we can provide information that will enable clinicians to remove barriers to&#xD;
      NPWT use. Additionally, we are seeking to use automated electronic medical record decision&#xD;
      support to identify patients that will benefit most from the NPWT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aim 1: Evaluate the effect of single-use NPWT on SSI rates after C-section,&#xD;
      abdominal hysterectomy, and colon procedures in at risk patients.&#xD;
&#xD;
      To address this aim, we will conduct multicenter, stepped-wedge, quasi-experimental trial&#xD;
      evaluating use of the PrevenaTM with 125 mm Hg negative pressure for 7 days among obese (BMI&#xD;
      &gt;30) and/or diabetic patients undergoing the procedures of interest. This is essentially a&#xD;
      phase IV clinical trial as this dressing has FDA approval for the indicated use.&#xD;
&#xD;
      Specific Aim 2: Investigate the patients' experience of using the NPWT. To achieve this aim,&#xD;
      we will survey a sub-set of patients to assess their knowledge of post-operative care, to&#xD;
      identify complications associated with NPWT use, and to learn how patients evaluated the&#xD;
      device's ease of use, ease of removal, and comfort.&#xD;
&#xD;
      Specific Aim 3: Assess whether real-time decision support through machine-learning modeling&#xD;
      can help surgeons identify patients at high risk of SSI who could benefit from NWPT or other&#xD;
      post-surgical preventive measures. To address this aim, we will evaluate whether boosted tree&#xD;
      modeling techniques can be used &quot;at the bedside&quot; via electronic medical record data feeds to&#xD;
      tailor post-operative care and preventive care for specific patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">April 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Randomized stepped wedge cluster but site</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Site Infection Rate per 100 surgeries</measure>
    <time_frame>within 30 days after surgery</time_frame>
    <description>Superficial , Deep and organ space infections after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Length of Stay (days)</measure>
    <time_frame>within 30days after surgery</time_frame>
    <description>days of ongoing admission after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>REadmission incidence and rate per 100 surgeries</measure>
    <time_frame>within 30 days</time_frame>
    <description>REadmission to hospital after discharge from surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seroma incidence and rate per 100 surgeries</measure>
    <time_frame>with in 30 days after surgery</time_frame>
    <description>Non infectious Fluid accumulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematoma incidence and rate per 100 surgeries</measure>
    <time_frame>within 30 days after surgery</time_frame>
    <description>Bloody fluid collection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dehiscence incidence and rate per 100 surgeries</measure>
    <time_frame>within 30 days after surgery</time_frame>
    <description>Loss of incision apposition</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3650</enrollment>
  <condition>Surgical Site Infection</condition>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NPWT use on closed incision for 7 days after c-section, abdominal hysterectomy, and colon surgery in patients with diabetes and/or obesity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Dressing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard dressing on closed incisions after c-section, abdominal hysterectomy, and colon surgery in patients with diabetes and/or obesity</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative Pressure Wound Therapy</intervention_name>
    <description>Occlusive dressing with attached Prevena incision management with 125mmHg of negative pressure and cartridge to manage secretions</description>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <other_name>Prevena Incision Management</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Category A and B&#xD;
&#xD;
        A. Patients undergoing any of the below procedures:&#xD;
&#xD;
          1. C-section&#xD;
&#xD;
          2. abdominal hysterectomy&#xD;
&#xD;
          3. colon procedures Surgical procedures selected will be based on NHSN designated ICD-10&#xD;
             PCS codes(14), with the exclusion of laparoscopic procedures.&#xD;
&#xD;
        B. and either of the following medical conditions:&#xD;
&#xD;
          1. obesity, BMI &gt;30 kg/m2&#xD;
&#xD;
          2. diabetes type 1 or 2 Criteria for a diagnosis of diabetes: Diabetes noted in the&#xD;
             problem list or the medical history or Patient is taking a medication as treatment for&#xD;
             diabetes, consistent with NHSN criteria(10).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age less than 18 years&#xD;
&#xD;
          2. Infection present at the time of the surgery&#xD;
&#xD;
          3. Laparoscopic procedures with incisions &lt;6cm.&#xD;
&#xD;
          4. Patients using alternative NPWT device other than the PrevenaTM with 125 mm Hg&#xD;
             negative pressure&#xD;
&#xD;
          5. Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Bleasdale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Health System</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 22, 2019</study_first_submitted>
  <study_first_submitted_qc>January 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Susan Casey Bleasdale</investigator_full_name>
    <investigator_title>Associate Professor of Clinical Medicine</investigator_title>
  </responsible_party>
  <keyword>colon surgery</keyword>
  <keyword>abdominal hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is a study with waiver of consent data will be in aggregate without patient identifiers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

